Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Sees Large Increase in Short Interest

Sol-Gel Technologies Ltd. (NASDAQ:SLGL) saw a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 8,600 shares, a growth of 79.2% from the February 28th total of 4,800 shares. Currently, 0.1% of the shares of the company are short sold. Based on an average daily trading volume, of 497,000 shares, the days-to-cover ratio is presently 0.0 days.

Sol-Gel Technologies Price Performance

Shares of SLGL stock traded up $0.02 during mid-day trading on Friday, hitting $0.55. The stock had a trading volume of 45,028 shares, compared to its average volume of 252,800. The firm has a market cap of $15.32 million, a PE ratio of -1.62 and a beta of 1.29. The company’s 50-day simple moving average is $0.65 and its 200-day simple moving average is $0.69. Sol-Gel Technologies has a fifty-two week low of $0.33 and a fifty-two week high of $1.65.

Hedge Funds Weigh In On Sol-Gel Technologies

An institutional investor recently bought a new position in Sol-Gel Technologies stock. Raymond James Financial Inc. acquired a new position in Sol-Gel Technologies Ltd. (NASDAQ:SLGL) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 108,990 shares of the company’s stock, valued at approximately $101,000. Raymond James Financial Inc. owned approximately 0.39% of Sol-Gel Technologies as of its most recent filing with the Securities and Exchange Commission (SEC). 26.18% of the stock is currently owned by institutional investors.

Sol-Gel Technologies Company Profile

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc, develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea.